SCC
IQMD

Spring Creek Capital’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Spring Creek Capital’s Portfolio IQMD Stock Details IQMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-250,000
Closed -$2.5M – 469
2022
Q1 		$2.5M Buy
+250,000
New +$2.48M 0.1% 214

Other funds holding IQMD

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Spring Creek Capital's IQMD Position: Q2 2022 in Review

Spring Creek Capital sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q2 2022, closing a stake of 250,000 shares — an estimated $2.5M sold.

Spring Creek Capital first reported a position in IQMD in Q1 2022 and held it in 1 quarter. The position peaked at $2.5M in Q1 2022. 58 funds tracked by Wall St. Rank hold IQMD as of Q2 2022.

  • Spring Creek Capital reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Spring Creek Capital sold 250,000 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q2 2022, an estimated $2.5M.
  • Spring Creek Capital first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 1 quarter.
  • Spring Creek Capital's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $2.5M in Q1 2022.
  • 58 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q2 2022.

Based on Spring Creek Capital's 13F filing for Q2 2022.